Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
TardbpKO

Posted 11 October 2010

General Information

The Tardbp gene, was isolated from a C57BL/6 genomic BAC clone (RP23-331p21; BACPAC). Conditional Tardbp-KO mouse line generated by engineering a targeting vector in which the 3rd exon of Tardbp was flanked by loxp together with a neomycin resistance gene inserted in the 2nd intron; The neomycin cassette was subsequently deleted through a crossbreeding strategy with hACTB-flp transgenic mice. The floxed Tardbp mice were crossbred with a CAG-Cre transgenic mouse line that express the Cre recombinase ubiquitously to generate the heterozygous Tardbp-KO (Tardbp+/-) mice.

Mutation: Conditional deletion of exon 3 of Tardbp.

Promoter: N/A

Mouse strain: V26.2 C57BL/6j ES cells; injected into albino C57BL/6J; Background: C57BL/6; Generation: F3, N3.

Phenotype

Neuropathological analysis:

Behavioral Phenotype:

Tardbp+/- mice were fertile and expressed similar level of TDP-43 in a variety of tissues compared with those of Tardbp+/+ mice. Postnatal deletion of Tardbp in mice caused dramatic loss of body fat followed by rapid death. Moreover, conditional Tardbp-Ko ES cells failed to proliferate.

Availability

Contact: Philip C. Wong
Department of Pathology, Division of Neuropathology
The Johns Hopkins University School of Medicine
558 Ross Research Building
720 Rutland Avenue
Baltimore, Maryland 21205-2196
Phone: 410-502-5168
Fax: 410-955-9777
E-mail: Philip C. Wong

References

Primary:

Chiang P-M, Ling J, Jeong H-Y, Price DL, Aja SM, Wong PC. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. PNAS 107:16320, 2010. Abstract

Associated:

Shan, X, Chiang P-M, Price DL and Wong, PC. Altered distribution of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. PNAS 107:16325, 2010. Abstract
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad